Metabotropic glutamate receptors as targets for analgesia: Antagonism, activation, and allosteric modulation

Current Pharmaceutical Biotechnology

Volumn 12, Issue 10, 2011, Pages 1681-1688

  Montana, Michael C ^a   Gereau IV, Robert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; mGluR; Pain; Sensitization

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 3,4 DCPG; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; ADX 10059; AMN 082; ANALGESIC AGENT; APDC; CPCCOET; EGLUMETAD; FENOBAM; KETAMINE; L AP 3; L AP4; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; MORPHINE; N ACETYLASPARTYLGLUTAMIC ACID; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERALGESIA; MIGRAINE; NERVE CELL EXCITABILITY; NERVOUS SYSTEM; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PSYCHOMETRY; SYNAPTIC TRANSMISSION;

ANIMALIA; VERTEBRATA;

EID: 80053505880     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798357438     Document Type: Article

References (95)

1. Masu, M.; Tanabe, Y.; Tsuchida, K.; Shigemoto, R.; Nakanishi, S. Sequence and expression of a metabotropic glutamate receptor. Nature, 1991, 349 (6312), 760-765.
2. Varney, M. A.; Gereau, R. W. t., Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Curr. Drug Targets, 2002, 1 (3), 283-296.
3. Bhave, G.; Karim, F.; Carlton, S. M.; Gereau, R. W. T. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat. Neurosci. 2001, 4 (4), 417-423.
4. Conn, P. J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann. N. Y. Acad. Sci., 2003, 1003, 12-21.
5. Knoflach, F.; Kemp, J. A. Metabotropic glutamate group II receptors activate a G protein-coupled inwardly rectifying K+ current in neurones of the rat cerebellum. J. physiol., 1998, 509 (Pt 2), 347-354.
6. Watanabe, D.; Nakanishi, S., mGluR2 postsynaptically senses granule cell inputs at Golgi cell synapses. Neuron, 2003, 39 (5), 821-829.
7. Conn, P. J.; Pin, J. P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 205-237.
8. Testa, C. M.; Friberg, I. K.; Weiss, S. W.; Standaert, D. G. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. J. Comparative Neurol., 1998, 390 (1), 5-19.
9. Lovinger, D. M.; McCool, B. A. Metabotropic glutamate receptormediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3. J. Neurophysiol., 1995, 73 (3), 1076-1083.
10. Conn, P. J.; Christopoulos, A.; Lindsley, C. W. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat. Rreview, 2009, 8 (1), 41-54.
11. Ferraguti, F.; Shigemoto, R. Metabotropic glutamate receptors. Cell Tissue Res., 2006, 326 (2), 483-504.
12. Martin, L. J.; Blackstone, C. D.; Huganir, R. L.; Price, D. L. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron, 1992, 9 (2), 259-270.
13. Schneider, F.; Habel, U.; Holthusen, H.; Kessler, C.; Posse, S.; Muller-Gartner, H. W.; Arndt, J. O. Subjective ratings of pain correlate with subcortical-limbic blood flow: an fMRI study. Neuropsychobiology, 2001, 43 (3), 175-185.
14. Ji, G.; Neugebauer, V. Hemispheric lateralization of pain processing by amygdala neurons. J. Neurophysiol., 2009, 102 (4), 2253-2264.
15. Kolber, B. J.; Montana, M. C.; Carrasquillo, Y.; Xu, J.; Heinemann, S. F.; Muglia, L. J.; Gereau, R. W. T. Activation of metabotropic glutamate receptor 5 in the amygdala modulates painlike behavior. J. Neurosci., 2010, 30 (24), 8203-8213.
16. Li, W.; Neugebauer, V. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain. J. Neurophysiol., 2006, 96 (4), 1803-1815.
17. Li, W.; Neugebauer, V. Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J. Neurophysiol., 2004, 91 (1), 13-24.
18. Lourenco Neto, F.; Schadrack, J.; Berthele, A.; Zieglgansberger, W.; Tolle, T. R.; Castro-Lopes, J. M. Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat. Brain Res., 2000, 854 (1-2), 93-105.
19. Jia, H.; Rustioni, A.; Valtschanoff, J. G. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J. Comparative Neurol., 1999, 410 (4), 627-642.
20. Karim, F.; Wang, C. C.; Gereau, R. W. T. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signalregulated kinase signaling required for inflammatory pain in mice. J. Neurosci., 2001, 21 (11), 3771-3779.
21. Chiechio, S.; Caricasole, A.; Barletta, E.; Storto, M.; Catania, M. V.; Copani, A.; Vertechy, M.; Nicolai, R.; Calvani, M.; Melchiorri, D.; Nicoletti, F. L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol. Pharmacol., 2002, 61 (5), 989-996.
22. Carlton, S. M.; Hargett, G. L. Colocalization of metabotropic glutamate receptors in rat dorsal root ganglion cells. J. Comparative Neurol., 2007, 501 (5), 780-789.
23. Valerio, A.; Rizzonelli, P.; Paterlini, M.; Moretto, G.; Knopfel, T.; Kuhn, R.; Memo, M.; Spano, P. mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study. Neurosci. Res., 1997, 28 (1), 49-57.
24. Young, M. R.; Fleetwood-Walker, S. M.; Mitchell, R.; Munro, F. E. Evidence for a role of metabotropic glutamate receptors in sustained nociceptive inputs to rat dorsal horn neurons. Neuropharmacology, 1994, 33 (1), 141-144.
25. Young, M. R.; Fleetwood-Walker, S. M.; Mitchell, R.; Dickinson, T. The involvement of metabotropic glutamate receptors and their intracellular signalling pathways in sustained nociceptive transmission in rat dorsal horn neurons. Neuropharmacology, 1995, 34 (8), 1033-1041.
26. Neugebauer, V.; Lucke, T.; Schaible, H. G. Requirement of metabotropic glutamate receptors for the generation of inflammationevoked hyperexcitability in rat spinal cord neurons. Eur. J. Neurosci., 1994, 6 (7), 1179-1186.
27. Schoepp, D. D.; Jane, D. E.; Monn, J. A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology, 1999, 38 (10), 1431-1476.
28. Neugebauer, V.; Chen, P. S.; Willis, W. D. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells. J. Neurophysiol., 1999, 82 (1), 272-282.
29. Dolan, S.; Nolan, A. M. Behavioural evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission. Neuropharmacology, 2000, 39 (7), 1132-1138.
30. Maione, S.; Oliva, P.; Marabese, I.; Palazzo, E.; Rossi, F.; Berrino, L.; Filippelli, A. Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception. Pain, 2000, 85 (1-2), 183-189.
31. Gasparini, F.; Lingenhohl, K.; Stoehr, N.; Flor, P. J.; Heinrich, M.; Vranesic, I.; Biollaz, M.; Allgeier, H.; Heckendorn, R.; Urwyler, S.; Varney, M. A.; Johnson, E. C.; Hess, S. D.; Rao, S. P.; Sacaan, A. I.; Santori, E. M.; Velicelebi, G.; Kuhn, R. 2-Methyl-6- (phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 1999, 38 (10), 1493-503.
32. Cosford, N. D.; Tehrani, L.; Roppe, J.; Schweiger, E.; Smith, N. D.; Anderson, J.; Bristow, L.; Brodkin, J.; Jiang, X.; McDonald, I.; Rao, S.; Washburn, M.; Varney, M. A. 3-[(2-Methyl-1,3-thiazol-4- yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J. Med, Chem., 2003, 46 (2), 204-206.
33. Lea, P. M. t.; Faden, A. I., Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev., 2006, 12 (2), 149-166.
34. Walker, K.; Bowes, M.; Panesar, M.; Davis, A.; Gentry, C.; Kesingland, A.; Gasparini, F.; Spooren, W.; Stoehr, N.; Pagano, A.; Flor, P. J.; Vranesic, I.; Lingenhoehl, K.; Johnson, E. C.; Varney, M.; Urban, L.; Kuhn, R., Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacol., 2001, 40 (1), 1-9.
35. Walker, K.; Reeve, A.; Bowes, M.; Winter, J.; Wotherspoon, G.; Davis, A.; Schmid, P.; Gasparini, F.; Kuhn, R.; Urban, L., Mglu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology, 2001, 40(1), 10-19.
36. Hu, H. J.; Alter, B. J.; Carrasquillo, Y.; Qiu, C. S.; Gereau, R. W. t. Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J. Neurosci., 2007, 27 (48), 13181-13191.
37. Dogrul, A.; Ossipov, M. H.; Lai, J.; Malan, T. P. Jr.; Porreca, F. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR(5)) antagonist, in experimental neuropathic pain in rats. Neurosci. Lett., 2000, 292 (2), 115-118.
38. Urban, M. O.; Hama, A. T.; Bradbury, M.; Anderson, J.; Varney, M. A.; Bristow, L. Role of metabotropic glutamate receptor subtype 5 (mGluR5) in the maintenance of cold hypersensitivity following a peripheral mononeuropathy in the rat. Neuropharmacology, 2003, 44 (8), 983-993.
39. Zhu, C. Z.; Wilson, S. G.; Mikusa, J. P.; Wismer, C. T.; Gauvin, D. M.; Lynch, J. J., 3rd; Wade, C. L.; Decker, M. W.; Honore, P. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur. J. Pharmacol., 2004, 506 (2), 107-118.
40. Ji, G.; Neugebauer, V. Reactive oxygen species are involved in group I mGluR-mediated facilitation of nociceptive processing in amygdala neurons. J. Neurophysiol., 2010, 104 (1), 218-229.
41. Han, J. S.; Neugebauer, V. mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain. Pain, 2005, 113(1-2), 211-222.
42. Carrasquillo, Y.; Gereau, R. W. t. Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J. Neurosci., 2007, 27 (7), 1543-1551.
43. Lindstrom, E.; Brusberg, M.; Hughes, P. A.; Martin, C. M.; Brierley, S. M.; Phillis, B. D.; Martinsson, R.; Abrahamsson, C.; Larsson, H.; Martinez, V.; Blackshaw, L. A. Involvement of metabotropic glutamate 5 receptor in visceral pain. Pain, 2008, 137 (2), 295-305.
44. Varty, G. B.; Grilli, M.; Forlani, A.; Fredduzzi, S.; Grzelak, M. E.; Guthrie, D. H.; Hodgson, R. A.; Lu, S. X.; Nicolussi, E.; Pond, A. J.; Parker, E. M.; Hunter, J. C.; Higgins, G. A.; Reggiani, A.; Bertorelli, R. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology, 2005, 179 (1), 207-217.
45. Ballard, T. M.; Woolley, M. L.; Prinssen, E.; Huwyler, J.; Porter, R.; Spooren, W. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology, 2005, 179 (1), 218-229.
46. Zhou, S.; Komak, S.; Du, J.; Carlton, S. M. Metabotropic glutamate 1alpha receptors on peripheral primary afferent fibers: their role in nociception. Brain Res., 2001, 913 (1), 18-26.
47. Fundytus, M. E.; Osborne, M. G.; Henry, J. L.; Coderre, T. J.; Dray, A. Antisense oligonucleotide knockdown of mGluR1 alleviates hyperalgesia and allodynia associated with chronic inflammation. Pharmacol. Biochem. Behav., 2002, 73 (2), 401-410.
48. Conquet, F.; Bashir, Z. I.; Davies, C. H.; Daniel, H.; Ferraguti, F.; Bordi, F.; Franz-Bacon, K.; Reggiani, A.; Matarese, V.; Conde, F. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature, 1994, 372 (6503), 237-243.
49. Zhu, C. Z.; Baker, S.; O, E. I.-K.; Lehto, S. G.; Hollingsworth, P. R.; Gauvin, D. M.; Hernandez, G.; Zheng, G.; Chang, R.; Moreland, R. B.; Stewart, A. O.; Brioni, J. D.; Honore, P. Analgesic activity of metabotropic glutamate receptor 1 antagonists on spontaneous post-operative pain in rats. Eur. J. Pharmacol., 2008, 580 (3), 314-321.
50. O'Leary, D. M.; Movsesyan, V.; Vicini, S.; Faden, A. I. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate- mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br. J. Pharmacol., 2000, 131 (7), 1429-1437.
51. Movsesyan, V. A.; O'Leary, D. M.; Fan, L.; Bao, W.; Mullins, P. G.; Knoblach, S. M.; Faden, A. I. mGluR5 antagonists 2-methyl-6- (phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)- pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J. Pharmacol. Expe. Ther., 2001, 296 (1), 41-47.
52. Montana, M. C.; Cavallone, L. F.; Stubbert, K. K.; Stefanescu, A. D.; Kharasch, E. D.; Gereau, R. W. T. The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine. J. Pharmacol. Exp. Ther. 2009, 330 (3), 834-843.
53. Porter, R. H.; Jaeschke, G.; Spooren, W.; Ballard, T. M.; Buttelmann, B.; Kolczewski, S.; Peters, J. U.; Prinssen, E.; Wichmann, J.; Vieira, E.; Muhlemann, A.; Gatti, S.; Mutel, V.; Malherbe, P. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J. Pharmacol. Exp. Ther. 2005, 315 (2), 711-721.
54. Pecknold, J. C.; McClure, D. J.; Appeltauer, L. Fenobam in anxious outpatients. Curr. Ther. Res., 1980, 27, 119-123.
55. Pecknold, J. C.; McClure, D. J.; Appeltauer, L.; Wrzesinski, L.; Allan, T. Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. J. Clin. Psychopharmacol., 1982, 2 (2), 129-133.
56. Lapierre, Y. D.; Oyewumi, L. K. Fenobam: another anxiolytic? Curr. Ther. Res., 1982, 31, 95-101.
57. Friedmann, C. T. H.; Davis, L. J.; Ciccone, P. E. T. R. R., Phase II double blind controlled study of a new anxiolytic, fenobam (McN- 3377) vs placebo. Curr. Ther. Res., 1980, 27, 144-151.
58. Jacob, W.; Gravius, A.; Pietraszek, M.; Nagel, J.; Belozertseva, I.; Shekunova, E.; Malyshkin, A.; Greco, S.; Barberi, C.; Danysz, W. The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning. Neuropharmacology, 2009, 57 (2), 97-108.
59. Berry-Kravis, E.; Hessl, D.; Coffey, S.; Hervey, C.; Schneider, A.; Yuhas, J.; Hutchison, J.; Snape, M.; Tranfaglia, M.; Nguyen, D. V.; Hagerman, R. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J. Med. Genet., 2009, 46 (4), 266-271.
60. Keywood, C.; Wakefield, M. ADX10059, a negative allosteric modulator of mGluR5, demonstrates proof of concept for a role in the management of migraine, in a placebo controilled phase 2A study. Neuropharmacology, 2008, 55, 605.
61. Keywood, C.; Wakefield, M.; Tack, J. A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor- 5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease. Gut, 2009, 58 (9), 1192-1199.
62. Marin, J. C.; Goadsby, P. J. Glutamatergic fine tuning with ADX- 10059: a novel therapeutic approach for migraine? Exp. Opin. Investig. Drugs, 2010, 19 (4), 555-561.
63. Wroblewska, B.; Wroblewski, J. T.; Pshenichkin, S.; Surin, A.; Sullivan, S. E.; Neale, J. H. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem., 1997, 69 (1), 174-181.
64. Yamamoto, T.; Hirasawa, S.; Wroblewska, B.; Grajkowska, E.; Zhou, J.; Kozikowski, A.; Wroblewski, J.; Neale, J. H. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur. J. Neurosci., 2004, 20 (2), 483-494.
65. Yamamoto, T.; Kozikowski, A.; Zhou, J.; Neale, J. H. Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain. Mol. Pain, 2008, 4, 31.
66. Yamamoto, T.; Nozaki-Taguchi, N.; Sakashita, Y. Spinal N-acetylalpha- linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat. Brain Res., 2001, 909 (1-2), 138-144.
67. Yamamoto, T.; Saito, O.; Aoe, T.; Bartolozzi, A.; Sarva, J.; Zhou, J.; Kozikowski, A.; Wroblewska, B.; Bzdega, T.; Neale, J. H. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats. Eur. J. Neurosci., 2007, 25 (1), 147-158.
68. Nagel, J.; Belozertseva, I.; Greco, S.; Kashkin, V.; Malyshkin, A.; Jirgensons, A.; Shekunova, E.; Eilbacher, B.; Bespalov, A.; Danysz, W. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration. Neuropharmacology, 2006, 51 (7-8), 1163-1171.
69. Chopra, M.; Yao, Y.; Blake, T. J.; Hampson, D. R.; Johnson, E. C. The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor. J. Pharmacol. Exp. Therap., 2009, 330 (1), 212-219.
70. Yang, D.; Gereau, R. W. T. Peripheral group II metabotropic glutamate receptors (mGluR2/3) regulate prostaglandin E2-mediated sensitization of capsaicin responses and thermal nociception. J. Neurosci., 2002, 22 (15), 6388-6393.
71. Yang, D.; Gereau, R. W. t. Peripheral group II metabotropic glutamate receptors mediate endogenous anti-allodynia in inflammation. Pain, 2003, 106 (3), 411-417.
72. Simmons, R. M.; Webster, A. A.; Kalra, A. B.; Iyengar, S. Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol. Biochem. Behav., 2002, 73 (2), 419-427.
73. Jones, C. K.; Eberle, E. L.; Peters, S. C.; Monn, J. A.; Shannon, H. E. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology, 2005, 49 (Suppl 1), 206-218.
74. Chiechio, S.; Copani, A.; Gereau, R. W. T.; Nicoletti, F. Acetyl-Lcarnitine in neuropathic pain: experimental data. CNS Drugs, 2007, 21 (Suppl 1), 31-38. Discussion 45-6.
75. Sima, A. A.; Calvani, M.; Mehra, M.; Amato, A. Acetyl-Lcarnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care, 2005, 28 (1), 89-94.
76. Chiechio, S.; Copani, A.; De Petris, L.; Morales, M. E.; Nicoletti, F.; Gereau, R. W. t. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Mol. Pain, 2006, 2, 20.
77. Ghelardini, C.; Galeotti, N.; Calvani, M.; Mosconi, L.; Nicolai, R.; Bartolini, A. Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats. Neuropharmacology, 2002, 43 (7), 1180-1187.
78. Chiechio, S.; Zammataro, M.; Morales, M. E.; Busceti, C. L.; Drago, F.; Gereau, R. W. t.; Copani, A.; Nicoletti, F. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol. Pharmacol., 2009, 75 (5), 1014-1020.
79. Neugebauer, V.; Chen, P. S.; Willis, W. D. Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells. J. Neurophysiol., 2000, 84 (6), 2998-3009.
80. Fisher, K.; Coderre, T. J. The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain, 1996, 68 (2-3), 255-263.
81. Conn, P. J.; Niswender, C. M. mGluR7's lucky number. Proc. Natl. Acad. Sci. USA, 2006, 103 (2), 251-252.
82. Thomas, N. K.; Wright, R. A.; Howson, P. A.; Kingston, A. E.; Schoepp, D. D.; Jane, D. E. (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology, 2001, 40 (3), 311-318.
83. Mitsukawa, K.; Yamamoto, R.; Ofner, S.; Nozulak, J.; Pescott, O.; Lukic, S.; Stoehr, N.; Mombereau, C.; Kuhn, R.; McAllister, K. H.; van der Putten, H.; Cryan, J. F.; Flor, P. J. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc. Natl. Acad. Sci. USA, 2005, 102 (51), 18712-18717.
84. Dolan, S.; Gunn, M. D.; Biddlestone, L.; Nolan, A. M. The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat. Behav. Pharmacol., 2009, 20(7) 596-604.
85. Palazzo, E.; Fu, Y.; Ji, G.; Maione, S.; Neugebauer, V. Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors. Neuropharmacology, 2008, 55 (4), 537-545.
86. Osikowicz, M.; Mika, J.; Makuch, W.; Przewlocka, B. Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain, 2008, 139 (1), 117-126.
87. Marabese, I.; Rossi, F.; Palazzo, E.; de Novellis, V.; Starowicz, K.; Cristino, L.; Vita, D.; Gatta, L.; Guida, F.; Di Marzo, V.; Rossi, F.; Maione, S. Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception. J. Neurophysiol., 2007, 98 (1), 43-53.
88. Marabese, I.; de Novellis, V.; Palazzo, E.; Scafuro, M. A.; Vita, D.; Rossi, F.; Maione, S. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice. Neuropharmacology, 2007, 52 (2), 253-262.
89. Marek, P.; Ben-Eliyahu, S.; Gold, M.; Liebeskind, J. C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res., 1991, 547 (1), 77-81.
90. Popik, P.; Kozela, E.; Pilc, A. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. Br. J. Pharmacol., 2000, 130 (6), 1425-1431.
91. Sharif, R. N.; Osborne, M.; Coderre, T. J.; Fundytus, M. E. Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1. Br. J. Pharmacol., 2002, 136 (6), 865-872.
92. Kozela, E.; Pilc, A.; Popik, P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology, 2003, 165 (3), 245-251.
93. Mogil, J. S., Animal models of pain: progress and challenges. Nat. Rev. Neurosci., 2009, 10 (4), 283-294.
94. King, T.; Vera-Portocarrero, L.; Gutierrez, T.; Vanderah, T. W.; Dussor, G.; Lai, J.; Fields, H. L.; Porreca, F. Unmasking the tonicaversive state in neuropathic pain. Nat. Neurosci., 2009, 12 (11), 1364-1366.
95. Liu, F.; Grauer, S.; Kelley, C.; Navarra, R.; Graf, R.; Zhang, G.; Atkinson, P. J.; Popiolek, M.; Wantuch, C.; Khawaja, X.; Smith, D.; Olsen, M.; Kouranova, E.; Lai, M.; Pruthi, F.; Pulicicchio, C.; Day, M.; Gilbert, A.; Pausch, M. H.; Brandon, N. J.; Beyer, C. E.; Comery, T. A.; Logue, S.; Rosenzweig-Lipson, S.; Marquis, K. L. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]- oxadiazol-5-yl]-piper idin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J. Pharmacol. Exp. Ther., 2008, 327 (3), 827-839.